Institution
Banner Sun Health Research Institute
- 18running trials
- 19closed trials
- 1,863publications (OpenAlex)
Running trials
Active, not recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Active, not recruiting
Enrolling by invitation
Active, not recruiting
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
Enrolling by invitation
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease5 recruiting
- Mild cognitive impairment3 recruiting
- Parkinson disease3 recruiting
- Frontotemporal dementia1 recruiting
- Lewy body dementia1 recruiting
- Multiple system atrophy1 recruiting
Closed trials
Completed
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
Terminated
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Completed
Completed
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Completed
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Completed
Completed
Completed
Terminated
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Terminated
A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD
Completed
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
Terminated
Completed
Completed
Registry name variants (3)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Banner Sun Health Research Institute
Sun City, Arizona 85351
36 trials
Banner Sun Health Research Institute
Sun City, Arizona 85351
1 trial
Banner Sun Health Research Institute
Sun City, Arizona 85351
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Alzheimer disease134 works · 29 trials
- Lewy body dementia12 works · 3 trials
- Frontotemporal dementia8 works · 3 trials
- Multiple system atrophy4 works · 1 trial
Institution data: ROR 04gjkkf30 (CC0-1.0)Updated 15 Nov 2026